454
Views
16
CrossRef citations to date
0
Altmetric
Cornea

Rose Bengal-Mediated Photodynamic Antimicrobial Treatment of Acanthamoeba Keratitis

, , , , , , , , & show all
Pages 1205-1210 | Received 14 Aug 2019, Accepted 11 Feb 2020, Published online: 27 Feb 2020

References

  • Maycock NJ, Jayaswal R. Update on Acanthamoeba Keratitis: diagnosis, treatment, and outcomes. Cornea. 2016;35(5):713–20. doi:10.1097/ICO.0000000000000804.
  • Seal D. Acanthamoeba keratitis update—incidence, molecular epidemiology and new drugs for treatment. Eye. 2003;17(8):893–905. doi:10.1038/sj.eye.6700563.
  • Khan NA. Acanthamoeba: biology and increasing importance in human health. FEMS Microbiol Rev. 2006;30(4):564–95. doi:10.1111/j.1574-6976.2006.00023.x.
  • Hafezi F, Randleman JB. PACK-CXL: defining CXL for infectious keratitis. J Refract Surg. 2014;30(7):438–39. doi:10.3928/1081597X-20140609-01.
  • Iseli HP, Thiel MA, Hafezi F, Kampmeier J, Seiler T. Ultraviolet A/riboflavin corneal cross-linking for infectious keratitis associated with corneal melts. Cornea. 2008;27(5):590–94. doi:10.1097/ICO.0b013e318169d698.
  • Makdoumi K, Mortensen J, Sorkhabi O, Malmvall BE, Crafoord S. UVA-riboflavin photochemical therapy of bacterial keratitis: a pilot study. Graefes Arch Clin Exp Ophthalmol. 2012;250(1):95–102. doi:10.1007/s00417-011-1754-1.
  • Alio JL, Abbouda A, Valle DD, Del Castillo JM, Fernandez JA. Corneal cross linking and infectious keratitis: a systematic review with a meta-analysis of reported cases. J Ophthalmic Inflamm Infect. 2013;3(1):47. doi:10.1186/1869-5760-3-47.
  • Said DG, Elalfy MS, Gatzioufas Z, El-Zakzouk ES, Hassan MA, Saif MY, Zaki AA, Dua HS, Hafezi F. Collagen cross-linking with photoactivated riboflavin (PACK-CXL) for the treatment of advanced infectious keratitis with corneal melting. Ophthalmology. 2014;121(7):1377–82. doi:10.1016/j.ophtha.2014.01.011.
  • Kashiwabuchi RT, Carvalho FRS, Khan YA, De Freitas D, Foronda AS, Hirai FE, Campos MS, McDonnell PJ. Assessing efficacy of combined riboflavin and UV-A light (365 nm) treatment of Acanthamoeba trophozoites. Invest Ophthalmol Vis Sci. 2011;52(13):9333–38. doi:10.1167/iovs.11-8382.
  • Berra M, Galperin G, Boscaro G, Zarate J, Tau J, Chiaradia P, Berra A. Treatment of Acanthamoeba keratitis by corneal cross-linking. Cornea. 2013;32(2):174–78. doi:10.1097/ICO.0b013e31825cea99.
  • Lamy R, Chan E, Good SD, Cevallos V, Porco TC, Stewart JM. Riboflavin and ultraviolet A as adjuvant treatment against Acanthamoeba cysts. Clin Exp Ophthalmol. 2016;44(3):181–87. doi:10.1111/ceo.2016.44.issue-3.
  • Cristian C, Marco CDV, Arturo K, Claudio P, Miguel S, Rolf R, Remigio L, Leonidas T. Accelerated collagen cross-linking in the management of advanced Acanthamoeba keratitis. Arq Bras Oftalmol. 2019;82(2):103–06. doi:10.5935/0004-2749.20190018.
  • Arboleda A, Miller D, Cabot F, Taneja M, Aguilar MC, Alawa K, Amescua G, Yoo SH, Parel JM. Assessment of RB versus riboflavin photodynamic therapy for inhibition of fungal keratitis isolates. Am J Ophthalmol. 2014;158(1):64–70. doi:10.1016/j.ajo.2014.04.007.
  • Cherfan D, Verter EE, Melki S, Gisel TE, Doyle FJ Jr, Scarcelli G, Yun SH, Redmond RW, Kochevar IE. Collagen cross-linking using rose bengal and green light to increase corneal stiffness. Invest Ophthalmol Vis Sci. 2013;54(5):3426–33. doi:10.1167/iovs.12-11509.
  • Atalay HT, Dogruman-Al F, Sarzhanov F, Özmen MC, Tefon AB, Arıbaş YK, Bilgihan K. Effect of riboflavin/rose bengal-mediated PACK-CXL on acanthamoeba trophozoites and cysts in vitro. Curr Eye Res. 2018;43(11):1322–25. doi:10.1080/02713683.2018.1501074.
  • Ortillés Á, Goñi P, Rubio E, Sierra M, Gamez E, Fernandez MT, Benito M, Cristobal JA, Calvo B. A rabbit model of acanthamoeba keratitis: use of infected soft contact lenses after corneal epithelium debridement with a diamond burr. Invest Ophthalmol Vis Sci. 2017;58(2):1218–27. doi:10.1167/iovs.16-21100.
  • Ren M, Wu X. Evaluation of three different methods to establish animal models of Acanthamoeba keratitis. Yonsei Med J. 2010;51(1):121–27. doi:10.3349/ymj.2010.51.1.121.
  • Bilgihan K, Kalkanci A, Ozdemir HB, Yazar R, Karakurt F, Yuksel E, Otag F, Karabicak N, Arikan-Akdagli S. Evaluation of antifungal efficacy of 0.1% and 0.25% riboflavin with UVA: a comparative in vitro study. Curr Eye Res. 2016;41(8):1050–56. doi:10.3109/02713683.2015.1088956.
  • Galperin G, Berra M, Tau J, Boscaro G, Zarate J, Berra A. Treatment of fungal keratitis from Fusarium infection by corneal cross-linking. Cornea. 2012 Feb;31(2):176–80. doi:10.1097/ICO.0b013e318221cec7.
  • Martins SA, Combs JC, Noguera G, Camacho W, Wittmann P, Walther R, Cano M, Dick J, Behrens A. Antimicrobial efficacy of riboflavin/UVA combination (365 nm) in vitro for bacterial and fungal isolates: a potential new treatment for infectious keratitis. Invest Ophthalmol Vis Sci. 2008;49(8):3402–08. doi:10.1167/iovs.07-1592.
  • Halili F, Arboleda A, Durkee H, Taneja M, Miller D, Alawa KA, Aguilar MC, Amescua G, Flynn HW Jr, Parel JM. Rose bengaland riboflavin-mediated photodynamic therapy to inhibit methicillin-resistant staphylococcus aureus keratitis isolates. Am J Ophthalmol. 2016;166:194–202. doi:10.1016/j.ajo.2016.03.014.
  • Gallego-Muñoz P, Ibares-Frías L, Lorenzo E, Marcos S, Peréz-Merino P, Bekesi N, Kochevar IE, Martínez-García MC. Corneal wound repair after rose bengal and green light crosslinking: clinical and histologic study. Invest Ophthalmol Vis Sci. 2017;58(9):3471–80. doi:10.1167/iovs.16-21365.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.